Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study

Jose Novo Matos1, Jessie Rose Payne2, Joonbum Seo3,4

  • 1Clinical Science and Services, Royal Veterinary College, Hertfordshire, UK.

Insights

Lower left atrial systolic function may precede hypertrophic cardiomyopathy (HCM) in cats. Cardiovascular events are common in cats with HCM, even those without prior heart disease signs.

Area of Science:

  • Veterinary Cardiology
  • Feline Medicine
  • Cardiovascular Research

Background:

  • Hypertrophic cardiomyopathy (HCM) studies in cats often involve clinically affected animals, potentially biasing findings.
  • Limited data exists on factors predicting HCM development in cats without initial cardiac disease signs.

Purpose of the Study:

  • To identify clinical variables predicting HCM development in cats.
  • To assess the rate of cardiovascular events in cats with HCM not referred for cardiac issues.

Main Methods:

  • A prospective longitudinal study followed 107 shelter cats without initial cardiac or systemic disease.
  • Serial echocardiograms and Cox regression analysis identified HCM predictors.
  • Adverse cardiovascular events were tracked over a median of 5.6 years.

Main Results:

  • Nineteen of 107 cats developed HCM during the study.
  • Lower left atrial fractional shortening, higher left ventricular fractional shortening, and increased body weight predicted HCM development.
  • Cardiovascular events occurred in 21% of cats diagnosed with HCM.

Conclusions:

  • Reduced left atrial systolic function may be an early indicator of feline HCM.
  • Cardiovascular events are frequent in cats with HCM, highlighting the need for early detection and management.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41